The adjuvant and tumor-suppressive activities of the quinonyl [2,3-dimethoxy-5-methyl-6-(9'-carboxynonyl)-1,4-benzoquinone (QS-10)] derivatives of N-acetyl muramyl dipeptides were examined. N-Acetyl muramyl-L-valyl-D-isoglutamine (MurNAc-L-Val-D-isoGln), QS-10-MurNAc-L-Val-D-isoGln, and their methyl esters were shown to have potent adjuvant activity on the induction of delayedtype hypersensitivity to monoazobenzenarsonate-N-acetyl-L-tyrosine in guinea pigs and on the primary immune response against sheep erythrocytes in vitro; however, only QS-10-MurNAc-L-Val-D-isoGln methyl ester, i.e., QS-10-MurNAc-L-Val-D-Glu(OCH3)NH2 (quinonyl-MDP-66), was shown to be an active adjuvant for the induction of allogeneic killer T cells in mice and the suppression of tumor growth in syngeneic mice when it was administered as a suspension in phosphatebuffered saline. The effectiveness of the chain length of the quinonyl moiety in quinonyl-MDP-66 and the replacement of the L-valine residue with L-serine or L-threonine were also examined in comparison with the adjuvant and tumorsuppressive activities of quinonyl-MDP-66.
Synthetic N-acetyl muramyl-L-alanyl-D-isoglutamine (MurNAc-L-Ala-D-isoGln) was demonstrated to be the minimal structure of bacterial peptidoglycans required for adjuvant activity on immune responses (1, 2, 13, 19) .
Previously, MurNAc -L -Ala -D -isoGln was shown to be an active adjuvant for the induction of delayed-type hypersensitivity to monoazobenzenarsonate-N-acetyl-L-tyrosine (ABA-N-acetyl-L-tyrosine) in guinea pigs and for circulating antibody formation to bacterial a-amylase; however, it was inactive as an adjuvant for cellmediated cytotoxicity in allogeneic mice in vivo and for suppression of tumor growth in syngeneic mice (5, 8) .
Recently, we examined the effectiveness on the adjuvant activity of the replacement of the L-alanine residue by L-serine, L-valine, or glycine in MurNAc-L-Ala-D-isoGln and its 6-0-"mycoloyl" derivatives (6-0-mycoloyl, 6-0-nocardomycoloyl, and 6-0-corynomycoloyl) (6, 8, 21, 25) . It was shown that 6-0-mycoloyl-MurNAc-L-Ala-D-isoGln, 6-0-"mycoloyl"-MurNAc-L-Ser-DisoGln, and 6-0-"mycoloyl"-MurNAc-L-Val-DisoGln were less effective on the humoral immune response or on the function of carrierprimed helper T cells, but active as adjuvants for cell-mediated cytotoxicity in allogeneic mice and for induction of delayed-type hypersensitivity to ABA-N-acetyl-L-tyrosine in guinea pigs. In contrast, MurNAc-L-Ala-D-isoGln, MurNAc- L-Ser-D-isoGln, and MurNAc-L-Val-D-isoGln were inactive as adjuvants for cell-mediated cytotoxicity in allogeneic mice, but were active for the humoral immune response and for the induction of delayed-type hypersensitivity to ABA-N-acetyl-L-tyrosine in guinea pigs.
Consequently, we have concluded that the introduction of the "mycolic acid" residue as the lipophilic group into N-acetyl muramyl dipeptides modified qualitatively the adjuvant activity on the immune response, predominantly on the cellular immune response (6, 26) .
It has also been reported that related compounds of ubiquinone, such as QS-10 [2,3- Nocardia rubra cell wall skeleton was prepared by the method described previously (7) . The N. rubra cell wall skeleton and the quinonyl derivatives of Nacetyl muramyl dipeptide methyl esters are insoluble in water, and these adjuvants were used as suspensions in phosphate-buffered saline (PBS) Animals. Six-to eight-week-old, female inbred mice of C57BL/6J, DBA/2, BALB/c, and Hartley strain guinea pigs, weighing 350 to 400 g, were purchased from Shizuoka Experimental Animal Cooperative, Hamamatsu, Japan. The animals were given food (Nihon Nosan Kogyo Co. Ltd., Yokohama, Japan) and water freely.
Antigens. Crystalline bacterial a-amylase prepared from Bacillus subtilis was purchased from Seikagaku Kogyo Co. Ltd., Tokyo, Japan. ABA-N-acetyl-L-tyrosine and ABA-bacterial a-amylase were prepared by the method described previously (23 (16) with some modifications as described previously (5) .
For the determination of antibody response in vivo, four female C57BL/6J mice were sensitized intraperitoneally with SRBC (108) suspended in PBS with or without adjuvants. After 2 weeks, blood was obtained by micropipette from the retro-orbital vein. A hemagglutinin test against SRBC was performed by a microtitration method.
Cell-mediated cytotoxicity test. C57BL/6J inbred mice (H-2b) were immunized intraperitoneally with viable cells of mastocytoma P815-X2 (H-2d) in the presence or absence of a suspension of various adjuvants in PBS. On day 11 after immunization, a cell-mediated cytotoxicity assay was carried out, using the spleen cells of immunized mice and 61Cr-labeled mastocytoma P815-X2 cells by the method of Brunner et al. (10) Maximum chromium release was measured at complete cell lysis when target cells were frozen and thawed three times.
Assay for footpad reaction. Four female C57BL/ 6J mice were sensitized intraperitoneally with SRBC (106) suspended in PBS with or without adjuvants. After 4 days, an eliciting dose of 108 SRBC in a volume of 25 Ad was injected into one hind footpad. The degree of swelling was measured at 24 and 48 h after challenge. The footpad reaction was expressed as the difference in thickness between one foot injected with SRBC and the other injected with PBS.
Suppression test of transplantable tumor in syngeneic mice. A mixture of tumor cells (Meth-A) and adjuvants suspended in PBS was inoculated intradermally into the flanks of BALB/c mice. Tumor sizes at the inoculated site and survival rates were examined every week. The results shown in the tables were obtained at 4 weeks after tumor inoculation.
RESULTS
Adjuvant activity ofquinonyl derivatives of N-acetyl muramyl dipeptides. Table 1 shows the effects of synthetic adjuvants such as MurNAc-L-Val-D-isoGln, its methyl ester MurNAc-L-Val-D-Glu(OCH3)NH2, and their quinonyl derivatives on the primary immune response against SRBC in vitro. All of the synthetic adjuvants showed adjuvant activity on the formation of 19S plaque-forming cells to SRBC after 4 days of culture in vitro. In particular, QS-10-MurNAc-L-Val-D-isoGln (group 3b) showed remarkable adjuvant activity at a 10-,ug dose. The effect of the chain length of the quinonyl moiety in quinonyl-MDP-66 on the adjuvant and tumor-suppressive activities is shown in Table 2 . The short-chain quinonyl ( (Table 2 ). Both the L-serine and the L-threonine analogs of quinonyl-MDP-66 (groups 3 and 4) were also shown to be active as adjuvants for the induction of delayed-type hypersensitivity in guinea pigs; however, the Lserine analog was less active for the suppression of Meth-A in BALB/c mice when administered as a suspension in PBS. Table 3 bSee Table 2 , footnote b.
less effective for the suppression of tumor growth in comparison with the others (groups 1 through 4).
Furthermore, the adjuvant activity of quinonyl-MDP-66, which showed potent adjuvant and tumor-suppressive activities as described above, was examined in the following experiments.
Adjuvant activity of quinonyl-MDP-66 on footpad reaction and antibody formation in mice. Quinonyl-MDP-66 as a suspension in PBS showed potent adjuvant activity for footpad reaction at a 500-yg dose, and a 100-pg dose of N. rubra cell wall skeleton also had potent adjuvant and tumor-suppressive activities as reported previously (Table 5) . Although the N. rubra cell wall skeleton was also active as an adjuvant for footpad reaction at a 20-pg dose, quinonyl-MDP-66 was less active at 20-or 100-pg doses. Quinonyl-MDP-66 at a 500-lsg dose, as well as N. rubra cell wall skeleton at 20-or 100-ag doses, was shown to be effective for the humoral immune response. The hemagglutinin titer of quinonyl-MDP-66 was reduced in a dose-dependent manner.
DISCUSSION
Ubiquinone is well known as a fat-soluble vitamin having various biological activities, such as effects on the mitochondrial electron transport system, labilization or stabilization activity of the lysosomal membrane, the production of cyclic adenosine 3',5'-monophosphate phosphodiesterase, and adjuvancy on humoral immune response (15) . Imada and his co-workers (15) have reported that the metabolites of ubiquinone and their related compounds such as Q acid-I, Q acid-II, QS-10, and QS-3 have some biological activities which were also observed in ubiquinone homologs.
Previously, it has been clearly shown that related compounds of ubiquinone, as well as other fat-soluble vitamins such as a-tocopherol and phylloquinone (vitamin K1), were more or as adjuvant active as N-acetyl muramyl dipeptide for the circulating antibody formation to bacterial a-amylase in mice (3, 22) . The QS-10 used in this study was also shown to have marked adjuvant activity.
In this paper, we examined the adjuvant and tumor-suppressive activities of synthetic qui- plaque-forming cells to SRBC in vitro ( Table 1) . As described previously (9) , adjuvant activity for the development of delayed-type hypersensitivity in guinea pigs when the adjuvants were administered together with the antigen as a wa- ter-in-oil emulsion was shown. However, only quinonyl-MDP-66 was effective for the generation of killer T cells in allogeneic cell-mediated cytotoxicity in C57BL/6J mice and the suppression of tumor growth in syngeneic BALB/c mice (9) .
These results suggest that the lipophilicity which was given to MurNAc-L-Val-D-isoGln by esterifications with QS-10 and methanol played an important role for the adjuvant and tumorsuppressive activities of MurNAc-L-Val-DisoGin. This consideration was supported by evidence that the compounds esterified with QS-3 instead of QS-10 in quinonyl-MDP-66 were active for the induction of delayed-type hypersensitivity; however, they were inactive for the suppression of tumor growth in syngeneic mice ( Table 2, (Tables 3 and 4) . The results obtained above suggest that appropriate physicochemical properties were required for the adjuvant and tumor-suppressive activities of these synthetic adjuvants.
Quinonyl-MDP-66 used in the following experiments was more effective both for footpad reaction to SRBC in mice (Table 5 ) and for the induction of delayed-type hypersensitivity to ABA-N-acetyl-L-tyrosine in guinea pigs. It was also shown to be active as an adjuvant for the circulating antibody response to SRBC not only in vitro (Table 1) but also in vivo ( Table 5) . As reported previously (6, 26), 6-O-mycoloyl-N-acetyl muramyl dipeptides, in which the lipophilic mycolic acid residue was introduced into N-acetyl muramyl dipeptides, have adjuvant activity predominantly on the cellular immune response, such as delayed-type hypersensitivity and allogeneic cell-mediated cytotoxicity. However, quinonyl-MDP-66, in which the lipophilicity was similarly given to the N-acetyl muramyl dipeptide, has potent adjuvant activity not only on the cellular immune response but also on humoral immune response. Quinonyl-MDP-66 suppressed tumor (Meth-A) growth in syngeneic BALB/c mice when it was administered as a suspension in PBS, although the 6-O-mycoloyl derivatives of N-acetyl muramyl dipeptides had suppressive activities when administered as oilin-water emulsions. Quinonyl-MDP-66, which was treated with squalene and then suspended in 5.6% mannitol containing 0.2% Tween 80 to make an oil-in-water emulsion, also suppressed tumor growth in syngeneic mice (data not shown). In the suppression test described above, the induction of systemic tumor immunity in mice which suppressed tumor growth was demonstrated by the reinoculation of Meth-A cells Damais et al. (11, 12) reported previously that MurNAc-L-Ala-D-isoGln acts as a mitogen on mouse spleen cells when cultured for 4 or 5 days in serum-free medium supplemented with 2-mercaptoethanol and shows a different responsiveness in several strains of mice. We observed that MurNAc-L-Val-D-isoGln, MurNAc-L-Val-D-Glu(OCH3)NH2, and their quinonyl derivatives can slightly or hardly act as mitogens on spleen cells of C57BL/6J, BALB/c, and DBA/2 mice under the condition of a 3-day culture in RPMI 1640 medium containing 10% fetal bovine serum (data not shown).
It was found that quinonyl-MDP-66, as well as ubiquinone, could restore the reduced nicotinamide adenine dinucleotide oxidase and succinate oxidase activities of pentane-or acetonetreated beef heart mitochondrial preparations (Imada et al., unpublished data). Furthermore, ubiquinone was shown to have protective activity against doxorubicin-induced cardiotoxicity (14, 27) . Of interest is the combined effect of the quinonyl derivatives ofN-acetyl muramyl dipeptides on cancer chemotherapy.
Although the biological significance of the quinonyl (QS-10) group which combined in the 6-0 position of the muramic acid residue is not yet clear, the biological activities of QS-10, such as its interaction on the cell surface membrane in reference to its lipophilic properties, will play some roles in the development of potent adjuvant and tumor-suppressive activities of quinonyl-MDP-66 as a suspension in PBS.
It is expected that quinonyl-MDP-66, as a new synthetic adjuvant, will have more interesting biological activities besides those of 6-0-mycoloyl-N-acetyl muramyl dipeptide, as reported previously. LITERATURE CITED
